Edesa Biotechの収益
Edesa Biotechの収益は何ですか。
Edesa Biotech, Inc.の収益は0.00$です。
収益の定義は何ですか。
収入とは、企業が通常の事業活動から得た収入であり、通常は商品やサービスの顧客への売却による収入です。
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
NASDAQのセクタHealth Careにおける収益の企業と比べるEdesa Biotech
Edesa Biotechは何をしますか。
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Edesa Biotechと類似の収益
- Treasury Metalsの収益は-73.00CAD$です。
- County Internationalの収益は-64.00AUD$です。
- Ionの収益は-58.00CAD$です。
- Sphinx Resourcesの収益は-52.00CAD$です。
- Rugby Miningの収益は-42.00CAD$です。
- Adavale Resourcesの収益は-1.00AUD$です。
- Edesa Biotechの収益は0.00$です。
- France Tourisme Immobilier SAの収益は1.00€です。
- AZ Leasing SPAの収益は1.00€です。
- Fauvet-Girelの収益は1.00€です。
- Labrador Technologiesの収益は4.00CAD$です。
- PolarXの収益は4.00AUD$です。
- Ark Minesの収益は4.00AUD$です。